2018-2023 Global Rare Endocrine Disease Treatment Market Report (Status and Outlook)

October 2018 | 132 pages | ID: 20BFFD9E62FEN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

In this report, LP Information studies the present scenario (with the base year being 2017) and the growth prospects of global Rare Endocrine Disease Treatment market for 2018-2023.
The endocrine system is a chemical messenger system consisting of hormones, the group of glands of an organism that carry those hormones directly into the circulatory system to be carried towards distant target organs and the feedback loops of homeostasis that the hormones drive.
The rare endocrine disease treatment market is expected to grow rapidly over the forecast period owing to the increasing prevalence of rare endocrine diseases.

Over the next five years, LPI(LP Information) projects that Rare Endocrine Disease Treatment will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

This report presents a comprehensive overview, market shares and growth opportunities of Rare Endocrine Disease Treatment market by product type, application, key companies and key regions.

To calculate the market size, LP Information considers value generated from the sales of the following segments:

Segmentation by product type:

• Biologics
• Organic Compounds

Segmentation by application:

• Hospital Pharmacies
• Online Pharmacies
• Retail Pharmacies

We can also provide the customized separate regional or country-level reports, for the following regions:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Spain
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:

• Novartis
• Ipsen
• Pfizer
• Teva
• EMD Serono
• Novo Nordisk
• Eli Lilly
• Shire
• Amgen
• Corcept Therapeutics
• Novelion Therapeutics

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

RESEARCH OBJECTIVES

• To study and analyze the global Rare Endocrine Disease Treatment market size by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
• To understand the structure of Rare Endocrine Disease Treatment market by identifying its various subsegments.
• Focuses on the key global Rare Endocrine Disease Treatment players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
• To analyze the Rare Endocrine Disease Treatment with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the size of Rare Endocrine Disease Treatment submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

2018-2023 GLOBAL RARE ENDOCRINE DISEASE TREATMENT MARKET REPORT (STATUS AND OUTLOOK)

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Rare Endocrine Disease Treatment Market Size 2013-2023
  2.1.2 Rare Endocrine Disease Treatment Market Size CAGR by Region
2.2 Rare Endocrine Disease Treatment Segment by Type
  2.2.1 Biologics
  2.2.2 Organic Compounds
2.3 Rare Endocrine Disease Treatment Market Size by Type
  2.3.1 Global Rare Endocrine Disease Treatment Market Size Market Share by Type (2013-2018)
  2.3.2 Global Rare Endocrine Disease Treatment Market Size Growth Rate by Type (2013-2018)
2.4 Rare Endocrine Disease Treatment Segment by Application
  2.4.1 Hospital Pharmacies
  2.4.2 Online Pharmacies
  2.4.3 Retail Pharmacies
2.5 Rare Endocrine Disease Treatment Market Size by Application
  2.5.1 Global Rare Endocrine Disease Treatment Market Size Market Share by Application (2013-2018)
  2.5.2 Global Rare Endocrine Disease Treatment Market Size Growth Rate by Application (2013-2018)

3 GLOBAL RARE ENDOCRINE DISEASE TREATMENT BY PLAYERS

3.1 Global Rare Endocrine Disease Treatment Market Size Market Share by Players
  3.1.1 Global Rare Endocrine Disease Treatment Market Size by Players (2016-2018)
  3.1.2 Global Rare Endocrine Disease Treatment Market Size Market Share by Players (2016-2018)
3.2 Global Rare Endocrine Disease Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 RARE ENDOCRINE DISEASE TREATMENT BY REGIONS

4.1 Rare Endocrine Disease Treatment Market Size by Regions
4.2 Americas Rare Endocrine Disease Treatment Market Size Growth
4.3 APAC Rare Endocrine Disease Treatment Market Size Growth
4.4 Europe Rare Endocrine Disease Treatment Market Size Growth
4.5 Middle East & Africa Rare Endocrine Disease Treatment Market Size Growth

5 AMERICAS

5.1 Americas Rare Endocrine Disease Treatment Market Size by Countries
5.2 Americas Rare Endocrine Disease Treatment Market Size by Type
5.3 Americas Rare Endocrine Disease Treatment Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Rare Endocrine Disease Treatment Market Size by Countries
6.2 APAC Rare Endocrine Disease Treatment Market Size by Type
6.3 APAC Rare Endocrine Disease Treatment Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 EUROPE

7.1 Europe Rare Endocrine Disease Treatment by Countries
7.2 Europe Rare Endocrine Disease Treatment Market Size by Type
7.3 Europe Rare Endocrine Disease Treatment Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Rare Endocrine Disease Treatment by Countries
8.2 Middle East & Africa Rare Endocrine Disease Treatment Market Size by Type
8.3 Middle East & Africa Rare Endocrine Disease Treatment Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 GLOBAL RARE ENDOCRINE DISEASE TREATMENT MARKET FORECAST

10.1 Global Rare Endocrine Disease Treatment Market Size Forecast (2018-2023)
10.2 Global Rare Endocrine Disease Treatment Forecast by Regions
  10.2.1 Global Rare Endocrine Disease Treatment Forecast by Regions (2018-2023)
  10.2.2 Americas Market Forecast
  10.2.3 APAC Market Forecast
  10.2.4 Europe Market Forecast
  10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
  10.3.1 United States Market Forecast
  10.3.2 Canada Market Forecast
  10.3.3 Mexico Market Forecast
  10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
  10.4.1 China Market Forecast
  10.4.2 Japan Market Forecast
  10.4.3 Korea Market Forecast
  10.4.4 Southeast Asia Market Forecast
  10.4.5 India Market Forecast
  10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
  10.5.1 Germany Market Forecast
  10.5.2 France Market Forecast
  10.5.3 UK Market Forecast
  10.5.4 Italy Market Forecast
  10.5.5 Russia Market Forecast
  10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
  10.6.1 Egypt Market Forecast
  10.6.2 South Africa Market Forecast
  10.6.3 Israel Market Forecast
  10.6.4 Turkey Market Forecast
  10.6.5 GCC Countries Market Forecast
10.7 Global Rare Endocrine Disease Treatment Forecast by Type
10.8 Global Rare Endocrine Disease Treatment Forecast by Application

11 KEY PLAYERS ANALYSIS

11.1 Novartis
  11.1.1 Company Details
  11.1.2 Rare Endocrine Disease Treatment Product Offered
  11.1.3 Novartis Rare Endocrine Disease Treatment Revenue, Gross Margin and Market Share (2016-2018)
  11.1.4 Main Business Overview
  11.1.5 Novartis News
11.2 Ipsen
  11.2.1 Company Details
  11.2.2 Rare Endocrine Disease Treatment Product Offered
  11.2.3 Ipsen Rare Endocrine Disease Treatment Revenue, Gross Margin and Market Share (2016-2018)
  11.2.4 Main Business Overview
  11.2.5 Ipsen News
11.3 Pfizer
  11.3.1 Company Details
  11.3.2 Rare Endocrine Disease Treatment Product Offered
  11.3.3 Pfizer Rare Endocrine Disease Treatment Revenue, Gross Margin and Market Share (2016-2018)
  11.3.4 Main Business Overview
  11.3.5 Pfizer News
11.4 Teva
  11.4.1 Company Details
  11.4.2 Rare Endocrine Disease Treatment Product Offered
  11.4.3 Teva Rare Endocrine Disease Treatment Revenue, Gross Margin and Market Share (2016-2018)
  11.4.4 Main Business Overview
  11.4.5 Teva News
11.5 EMD Serono
  11.5.1 Company Details
  11.5.2 Rare Endocrine Disease Treatment Product Offered
  11.5.3 EMD Serono Rare Endocrine Disease Treatment Revenue, Gross Margin and Market Share (2016-2018)
  11.5.4 Main Business Overview
  11.5.5 EMD Serono News
11.6 Novo Nordisk
  11.6.1 Company Details
  11.6.2 Rare Endocrine Disease Treatment Product Offered
  11.6.3 Novo Nordisk Rare Endocrine Disease Treatment Revenue, Gross Margin and Market Share (2016-2018)
  11.6.4 Main Business Overview
  11.6.5 Novo Nordisk News
11.7 Eli Lilly
  11.7.1 Company Details
  11.7.2 Rare Endocrine Disease Treatment Product Offered
  11.7.3 Eli Lilly Rare Endocrine Disease Treatment Revenue, Gross Margin and Market Share (2016-2018)
  11.7.4 Main Business Overview
  11.7.5 Eli Lilly News
11.8 Shire
  11.8.1 Company Details
  11.8.2 Rare Endocrine Disease Treatment Product Offered
  11.8.3 Shire Rare Endocrine Disease Treatment Revenue, Gross Margin and Market Share (2016-2018)
  11.8.4 Main Business Overview
  11.8.5 Shire News
11.9 Amgen
  11.9.1 Company Details
  11.9.2 Rare Endocrine Disease Treatment Product Offered
  11.9.3 Amgen Rare Endocrine Disease Treatment Revenue, Gross Margin and Market Share (2016-2018)
  11.9.4 Main Business Overview
  11.9.5 Amgen News
11.10 Corcept Therapeutics
  11.10.1 Company Details
  11.10.2 Rare Endocrine Disease Treatment Product Offered
  11.10.3 Corcept Therapeutics Rare Endocrine Disease Treatment Revenue, Gross Margin and Market Share (2016-2018)
  11.10.4 Main Business Overview
  11.10.5 Corcept Therapeutics News
11.11 Novelion Therapeutics

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Table Product Specifications of Rare Endocrine Disease Treatment
Figure Rare Endocrine Disease Treatment Report Years Considered
Figure Market Research Methodology
Figure Global Rare Endocrine Disease Treatment Market Size Growth Rate 2013-2023 ($ Millions)
Table Rare Endocrine Disease Treatment Market Size CAGR by Region 2013-2023 ($ Millions)
Table Major Players of Biologics
Table Major Players of Organic Compounds
Table Market Size by Type (2013-2018) ($ Millions)
Table Global Rare Endocrine Disease Treatment Market Size Market Share by Type (2013-2018)
Figure Global Rare Endocrine Disease Treatment Market Size Market Share by Type (2013-2018)
Figure Global Biologics Market Size Growth Rate
Figure Global Organic Compounds Market Size Growth Rate
Figure Rare Endocrine Disease Treatment Consumed in Hospital Pharmacies
Figure Global Rare Endocrine Disease Treatment Market: Hospital Pharmacies (2013-2018) ($ Millions)
Figure Global Hospital Pharmacies YoY Growth ($ Millions)
Figure Rare Endocrine Disease Treatment Consumed in Online Pharmacies
Figure Global Rare Endocrine Disease Treatment Market: Online Pharmacies (2013-2018) ($ Millions)
Figure Global Online Pharmacies YoY Growth ($ Millions)
Figure Rare Endocrine Disease Treatment Consumed in Retail Pharmacies
Figure Global Rare Endocrine Disease Treatment Market: Retail Pharmacies (2013-2018) ($ Millions)
Figure Global Retail Pharmacies YoY Growth ($ Millions)
Table Global Rare Endocrine Disease Treatment Market Size by Application (2013-2018) ($ Millions)
Table Global Rare Endocrine Disease Treatment Market Size Market Share by Application (2013-2018)
Figure Global Rare Endocrine Disease Treatment Market Size Market Share by Application (2013-2018)
Figure Global Rare Endocrine Disease Treatment Market Size in Hospital Pharmacies Growth Rate
Figure Global Rare Endocrine Disease Treatment Market Size in Online Pharmacies Growth Rate
Figure Global Rare Endocrine Disease Treatment Market Size in Retail Pharmacies Growth Rate
Table Global Rare Endocrine Disease Treatment Revenue by Players (2016-2018) ($ Millions)
Table Global Rare Endocrine Disease Treatment Revenue Market Share by Players (2016-2018)
Figure Global Rare Endocrine Disease Treatment Revenue Market Share by Players in 2017
Table Global Rare Endocrine Disease Treatment Key Players Head office and Products Offered
Table Rare Endocrine Disease Treatment Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global Rare Endocrine Disease Treatment Market Size by Regions 2013-2018 ($ Millions)
Table Global Rare Endocrine Disease Treatment Market Size Market Share by Regions 2013-2018
Figure Global Rare Endocrine Disease Treatment Market Size Market Share by Regions 2013-2018
Figure Americas Rare Endocrine Disease Treatment Market Size 2013-2018 ($ Millions)
Figure APAC Rare Endocrine Disease Treatment Market Size 2013-2018 ($ Millions)
Figure Europe Rare Endocrine Disease Treatment Market Size 2013-2018 ($ Millions)
Figure Middle East & Africa Rare Endocrine Disease Treatment Market Size 2013-2018 ($ Millions)
Table Americas Rare Endocrine Disease Treatment Market Size by Countries (2013-2018) ($ Millions)
Table Americas Rare Endocrine Disease Treatment Market Size Market Share by Countries (2013-2018)
Figure Americas Rare Endocrine Disease Treatment Market Size Market Share by Countries in 2017
Table Americas Rare Endocrine Disease Treatment Market Size by Type (2013-2018) ($ Millions)
Table Americas Rare Endocrine Disease Treatment Market Size Market Share by Type (2013-2018)
Figure Americas Rare Endocrine Disease Treatment Market Size Market Share by Type in 2017
Table Americas Rare Endocrine Disease Treatment Market Size by Application (2013-2018) ($ Millions)
Table Americas Rare Endocrine Disease Treatment Market Size Market Share by Application (2013-2018)
Figure Americas Rare Endocrine Disease Treatment Market Size Market Share by Application in 2017
Figure United States Rare Endocrine Disease Treatment Market Size Growth 2013-2018 ($ Millions)
Figure Canada Rare Endocrine Disease Treatment Market Size Growth 2013-2018 ($ Millions)
Figure Mexico Rare Endocrine Disease Treatment Market Size Growth 2013-2018 ($ Millions)
Table APAC Rare Endocrine Disease Treatment Market Size by Countries (2013-2018) ($ Millions)
Table APAC Rare Endocrine Disease Treatment Market Size Market Share by Countries (2013-2018)
Figure APAC Rare Endocrine Disease Treatment Market Size Market Share by Countries in 2017
Table APAC Rare Endocrine Disease Treatment Market Size by Type (2013-2018) ($ Millions)
Table APAC Rare Endocrine Disease Treatment Market Size Market Share by Type (2013-2018)
Figure APAC Rare Endocrine Disease Treatment Market Size Market Share by Type in 2017
Table APAC Rare Endocrine Disease Treatment Market Size by Application (2013-2018) ($ Millions)
Table APAC Rare Endocrine Disease Treatment Market Size Market Share by Application (2013-2018)
Figure APAC Rare Endocrine Disease Treatment Market Size Market Share by Application in 2017
Figure China Rare Endocrine Disease Treatment Market Size Growth 2013-2018 ($ Millions)
Figure Japan Rare Endocrine Disease Treatment Market Size Growth 2013-2018 ($ Millions)
Figure Korea Rare Endocrine Disease Treatment Market Size Growth 2013-2018 ($ Millions)
Figure Southeast Asia Rare Endocrine Disease Treatment Market Size Growth 2013-2018 ($ Millions)
Figure India Rare Endocrine Disease Treatment Market Size Growth 2013-2018 ($ Millions)
Figure Australia Rare Endocrine Disease Treatment Market Size Growth 2013-2018 ($ Millions)
Table Europe Rare Endocrine Disease Treatment Market Size by Countries (2013-2018) ($ Millions)
Table Europe Rare Endocrine Disease Treatment Market Size Market Share by Countries (2013-2018)
Figure Europe Rare Endocrine Disease Treatment Market Size Market Share by Countries in 2017
Table Europe Rare Endocrine Disease Treatment Market Size by Type (2013-2018) ($ Millions)
Table Europe Rare Endocrine Disease Treatment Market Size Market Share by Type (2013-2018)
Figure Europe Rare Endocrine Disease Treatment Market Size Market Share by Type in 2017
Table Europe Rare Endocrine Disease Treatment Market Size by Application (2013-2018) ($ Millions)
Table Europe Rare Endocrine Disease Treatment Market Size Market Share by Application (2013-2018)
Figure Europe Rare Endocrine Disease Treatment Market Size Market Share by Application in 2017
Figure Germany Rare Endocrine Disease Treatment Market Size Growth 2013-2018 ($ Millions)
Figure France Rare Endocrine Disease Treatment Market Size Growth 2013-2018 ($ Millions)
Figure UK Rare Endocrine Disease Treatment Market Size Growth 2013-2018 ($ Millions)
Figure Italy Rare Endocrine Disease Treatment Market Size Growth 2013-2018 ($ Millions)
Figure Russia Rare Endocrine Disease Treatment Market Size Growth 2013-2018 ($ Millions)
Figure Spain Rare Endocrine Disease Treatment Market Size Growth 2013-2018 ($ Millions)
Table Middle East & Africa Rare Endocrine Disease Treatment Market Size by Countries (2013-2018) ($ Millions)
Table Middle East & Africa Rare Endocrine Disease Treatment Market Size Market Share by Countries (2013-2018)
Figure Middle East & Africa Rare Endocrine Disease Treatment Market Size Market Share by Countries in 2017
Table Middle East & Africa Rare Endocrine Disease Treatment Market Size by Type (2013-2018) ($ Millions)
Table Middle East & Africa Rare Endocrine Disease Treatment Market Size Market Share by Type (2013-2018)
Figure Middle East & Africa Rare Endocrine Disease Treatment Market Size Market Share by Type in 2017
Table Middle East & Africa Rare Endocrine Disease Treatment Market Size by Application (2013-2018) ($ Millions)
Table Middle East & Africa Rare Endocrine Disease Treatment Market Size Market Share by Application (2013-2018)
Figure Middle East & Africa Rare Endocrine Disease Treatment Market Size Market Share by Application in 2017
Figure Egypt Rare Endocrine Disease Treatment Market Size Growth 2013-2018 ($ Millions)
Figure South Africa Rare Endocrine Disease Treatment Market Size Growth 2013-2018 ($ Millions)
Figure Israel Rare Endocrine Disease Treatment Market Size Growth 2013-2018 ($ Millions)
Figure Turkey Rare Endocrine Disease Treatment Market Size Growth 2013-2018 ($ Millions)
Figure GCC Countries Rare Endocrine Disease Treatment Market Size Growth 2013-2018 ($ Millions)
Figure Global Rare Endocrine Disease Treatment arket Size Forecast (2018-2023) ($ Millions)
Table Global Rare Endocrine Disease Treatment Market Size Forecast by Regions (2018-2023) ($ Millions)
Table Global Rare Endocrine Disease Treatment Market Size Market Share Forecast by Regions
Figure Americas Rare Endocrine Disease Treatment Market Size 2018-2023 ($ Millions)
Figure APAC Rare Endocrine Disease Treatment Market Size 2018-2023 ($ Millions)
Figure Europe Rare Endocrine Disease Treatment Market Size 2018-2023 ($ Millions)
Figure Middle East & Africa Rare Endocrine Disease Treatment Market Size 2018-2023 ($ Millions)
Figure United States Rare Endocrine Disease Treatment Market Size 2018-2023 ($ Millions)
Figure Canada Rare Endocrine Disease Treatment Market Size 2018-2023 ($ Millions)
Figure Mexico Rare Endocrine Disease Treatment Market Size 2018-2023 ($ Millions)
Figure Brazil Rare Endocrine Disease Treatment Market Size 2018-2023 ($ Millions)
Figure China Rare Endocrine Disease Treatment Market Size 2018-2023 ($ Millions)
Figure Japan Rare Endocrine Disease Treatment Market Size 2018-2023 ($ Millions)
Figure Korea Rare Endocrine Disease Treatment Market Size 2018-2023 ($ Millions)
Figure Southeast Asia Rare Endocrine Disease Treatment Market Size 2018-2023 ($ Millions)
Figure India Rare Endocrine Disease Treatment Market Size 2018-2023 ($ Millions)
Figure Australia Rare Endocrine Disease Treatment Market Size 2018-2023 ($ Millions)
Figure Germany Rare Endocrine Disease Treatment Market Size 2018-2023 ($ Millions)
Figure France Rare Endocrine Disease Treatment Market Size 2018-2023 ($ Millions)
Figure UK Rare Endocrine Disease Treatment Market Size 2018-2023 ($ Millions)
Figure Italy Rare Endocrine Disease Treatment Market Size 2018-2023 ($ Millions)
Figure Russia Rare Endocrine Disease Treatment Market Size 2018-2023 ($ Millions)
Figure Spain Rare Endocrine Disease Treatment Market Size 2018-2023 ($ Millions)
Figure Egypt Rare Endocrine Disease Treatment Market Size 2018-2023 ($ Millions)
Figure South Africa Rare Endocrine Disease Treatment Market Size 2018-2023 ($ Millions)
Figure Israel Rare Endocrine Disease Treatment Market Size 2018-2023 ($ Millions)
Figure Turkey Rare Endocrine Disease Treatment Market Size 2018-2023 ($ Millions)
Figure GCC Countries Rare Endocrine Disease Treatment Market Size 2018-2023 ($ Millions)
Table Global Rare Endocrine Disease Treatment Market Size Forecast by Type (2018-2023) ($ Millions)
Table Global Rare Endocrine Disease Treatment Market Size Market Share Forecast by Type (2018-2023)
Table Global Rare Endocrine Disease Treatment Market Size Forecast by Application (2018-2023) ($ Millions)
Table Global Rare Endocrine Disease Treatment Market Size Market Share Forecast by Application (2018-2023)
Table Novartis Basic Information, Head Office, Major Market Areas and Its Competitors
Table Novartis Rare Endocrine Disease Treatment Revenue and Gross Margin (2016-2018)
Figure Novartis Rare Endocrine Disease Treatment Market Share (2016-2018)
Table Ipsen Basic Information, Head Office, Major Market Areas and Its Competitors
Table Ipsen Rare Endocrine Disease Treatment Revenue and Gross Margin (2016-2018)
Figure Ipsen Rare Endocrine Disease Treatment Market Share (2016-2018)
Table Pfizer Basic Information, Head Office, Major Market Areas and Its Competitors
Table Pfizer Rare Endocrine Disease Treatment Revenue and Gross Margin (2016-2018)
Figure Pfizer Rare Endocrine Disease Treatment Market Share (2016-2018)
Table Teva Basic Information, Head Office, Major Market Areas and Its Competitors
Table Teva Rare Endocrine Disease Treatment Revenue and Gross Margin (2016-2018)
Figure Teva Rare Endocrine Disease Treatment Market Share (2016-2018)
Table EMD Serono Basic Information, Head Office, Major Market Areas and Its Competitors
Table EMD Serono Rare Endocrine Disease Treatment Revenue and Gross Margin (2016-2018)
Figure EMD Serono Rare Endocrine Disease Treatment Market Share (2016-2018)
Table Novo Nordisk Basic Information, Head Office, Major Market Areas and Its Competitors
Table Novo Nordisk Rare Endocrine Disease Treatment Revenue and Gross Margin (2016-2018)
Figure Novo Nordisk Rare Endocrine Disease Treatment Market Share (2016-2018)
Table Eli Lilly Basic Information, Head Office, Major Market Areas and Its Competitors
Table Eli Lilly Rare Endocrine Disease Treatment Revenue and Gross Margin (2016-2018)
Figure Eli Lilly Rare Endocrine Disease Treatment Market Share (2016-2018)
Table Shire Basic Information, Head Office, Major Market Areas and Its Competitors
Table Shire Rare Endocrine Disease Treatment Revenue and Gross Margin (2016-2018)
Figure Shire Rare Endocrine Disease Treatment Market Share (2016-2018)
Table Amgen Basic Information, Head Office, Major Market Areas and Its Competitors
Table Amgen Rare Endocrine Disease Treatment Revenue and Gross Margin (2016-2018)
Figure Amgen Rare Endocrine Disease Treatment Market Share (2016-2018)
Table Corcept Therapeutics Basic Information, Head Office, Major Market Areas and Its Competitors
Table Corcept Therapeutics Rare Endocrine Disease Treatment Revenue and Gross Margin (2016-2018)
Figure Corcept Therapeutics Rare Endocrine Disease Treatment Market Share (2016-2018)
Table Novelion Therapeutics Basic Information, Head Office, Major Market Areas and Its Competitors